While most asthma studies have focused on assessing the total monocyte numbers, one study in particular, by Moniuszko et al. [22], demonstrated a significant increase in the intermediate CD14++CD16+ monocyte percentage in patients with severe asthma compared to healthy controls or to patients with mild and moderate asthma [22]. The gene discussed is FCGR3A; the disease is asthma.